| Literature DB >> 29962913 |
Julia Alexandra Hunter1, Taehoon Lee2, Navindra Persaud3.
Abstract
OBJECTIVES: The research compared the comprehensiveness and accuracy of two online resources that provide drug information: Lexicomp and Wikipedia.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29962913 PMCID: PMC6013145 DOI: 10.5195/jmla.2018.256
Source DB: PubMed Journal: J Med Libr Assoc ISSN: 1536-5050
Figure 1Number of medications containing information in specific medication information subcategories
Subcategory content comparison for Lexicomp and Wikipedia medication information
| Category | Subcategory | Levothyroxine | Atorvastatin | Pantoprazole | Acetylsalicylic acid | Metformin |
|---|---|---|---|---|---|---|
| Dosing and instructions | Adult dosing | L+W D* | L | L | L+W D* | L |
| Geriatric dosing | L | L | L | L | L | |
| Pediatric dosing | L | L | L | L | L | |
| Hepatic impairment dosing | L | L+W ND | L | L | L+W ND | |
| Renal impairment dosing | L | L | L | L | L+W ND | |
| Adjustment for toxicity | L | L | N | N | N | |
| Administration | L+W D * | L+W D* | L | L | L | |
| Uses | Uses | L+W ND | L+W ND | L+W D* | L+W D* | L+W D* |
| Adverse effects or warnings | Safety considerations | L | L | L | L | L |
| Contraindications or disease-related concerns | L+W D* | L+W D* | L | L+W D | L+W D* | |
| Concerns for special populations | L+W ND | L+W D* | L+W D* | L | L+W ND | |
| Dosage form considerations | L | L | L | L | L | |
| Other | L | L | L | L+W ND | N | |
| Pregnancy risk factor or considerations | L+W ND | L+W ND | L+W ND | L+W ND | L+W ND | |
| Breast feeding considerations | L+W ND | L+W ND | L+W ND | L | L | |
| Adverse reactions | L+W D* | L+W D* | L+W D* | L+W D* | L+W D* |
N=present in neither.
W=present in Wikipedia only.
L=present in Lexicomp only.
L+W D=present in both with discrepancies.
L+W D*=present in both with discrepancies, more information in Lexicomp.
L+W ND=present in both without discrepancies.
Literature search reporting characteristics, systematic reviews sample (n=75)
| Levothyroxine | Atorvastatin | Pantoprazole | Acetylsalicylic acid | Metformin | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Number of adverse reactions listed only in Lexicomp or only in Wikipedia | ||||||||||
| Lexicomp | 21 | 58 | 145 | 59 | 19 | |||||
| Wikipedia | 3 | 0 | 1 | 0 | 3 | |||||
| Adverse reactions listed only in Lexicomp or only in Wikipedia supported by an inline citation | ||||||||||
| Lexicomp | 0 | (—) | 1 | (1.7%) | 2 | (1.4%) | 1 | (1.7%) | 0 | (—) |
| Wikipedia | 1 | (33.3%) | 0 | (—) | 1 | (100.0%) | 0 | (—) | ||
| Inline reference provided is primary literature | ||||||||||
| Lexicomp | 0 | (—) | 1 | (1.7%) | 1 | (0.7%) | 0 | (—) | 0 | (—) |
| Wikipedia | 0 | (—) | 0 | (—) | 0 | (—) | 3 | (100.0%) | ||
| Retrieved supporting reference from primary literature | ||||||||||
| Lexicomp | 14 | (66.7%) | 46 | (79.3%) | 65 | (44.8%) | 50 | (84.7%) | 16 | (84.2%) |
| Wikipedia | 3 | (100.0%) | 0 | (—) | 1 | (100.0%) | 0 | (—) | 3 | (100.0%) |
| Number of adverse events unsupported in Lexicomp following primary literature search | ||||||||||
| Lexicomp | 7 | 12 | 80 | 9 | 3 | |||||
| Number of previously unsupported adverse events in Lexicomp supported by US Food and Drug Administration (FDA) Prescribing Information (PI) | ||||||||||
| Lexicomp | 3 | (42.9%) | 9 | (75.0%) | 4 | (5.0%) | — | — | 1 | (33.3%) |
| Number of previously unsupported adverse events in Lexicomp supported by FDA Adverse Events Reporting Systems (FAERS) Dashboard | ||||||||||
| Lexicomp | 7 | (100.0%) | 11 | (91.7%) | 71 | (88.8%) | — | — | 3 | (100.0%) |
| Number of adverse events in Lexicomp remaining unsupported | ||||||||||
| Lexicomp | 0 | (—) | 1 | (8.3%) | 9 | (11.2%) | 9 | (100.0%) | 0 | (—) |
These values included both references provided by the inline source indicated and those retrieved through a fact-checking literature search.